MX2021015591A - Composiciones que comprenden iga secretora y probioticos. - Google Patents

Composiciones que comprenden iga secretora y probioticos.

Info

Publication number
MX2021015591A
MX2021015591A MX2021015591A MX2021015591A MX2021015591A MX 2021015591 A MX2021015591 A MX 2021015591A MX 2021015591 A MX2021015591 A MX 2021015591A MX 2021015591 A MX2021015591 A MX 2021015591A MX 2021015591 A MX2021015591 A MX 2021015591A
Authority
MX
Mexico
Prior art keywords
compositions
probiotics
secretory iga
methods
relates
Prior art date
Application number
MX2021015591A
Other languages
English (en)
Inventor
Laurent Favre
Daniel Hugelshofer
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MX2021015591A publication Critical patent/MX2021015591A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se relaciona con métodos para producir composiciones que comprenden IgA secretora y uno o más probióticos. En particular, la invención se relaciona con métodos para producir composiciones en las cuales se asocian la IgA secretora y uno o más probióticos. La invención también se relaciona con composiciones que pueden obtenerse mediante los métodos y usos de las composiciones, por ejemplo, para reducir o prevenir una infección y/o inflamación no viral.
MX2021015591A 2019-06-28 2020-06-25 Composiciones que comprenden iga secretora y probioticos. MX2021015591A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19183393 2019-06-28
PCT/EP2020/067906 WO2020260502A1 (en) 2019-06-28 2020-06-25 COMPOSITIONS COMPRISING SECRETORY IgA AND PROBIOTICS

Publications (1)

Publication Number Publication Date
MX2021015591A true MX2021015591A (es) 2022-03-11

Family

ID=67145532

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021015591A MX2021015591A (es) 2019-06-28 2020-06-25 Composiciones que comprenden iga secretora y probioticos.

Country Status (8)

Country Link
US (1) US20220296706A1 (es)
EP (1) EP3990485A1 (es)
CN (1) CN114502582A (es)
AU (1) AU2020306842A1 (es)
BR (1) BR112021024793A2 (es)
CL (1) CL2021003328A1 (es)
MX (1) MX2021015591A (es)
WO (1) WO2020260502A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4034145A4 (en) * 2019-09-24 2023-10-11 The Regents of the University of California BENEFICIAL BACTERIA AND SECRETORY IMMUNOGLOBULIN A
AU2022420738A1 (en) 2021-12-20 2024-05-30 Société des Produits Nestlé S.A. Secretory iga-biotic complexes and uses thereof
CN116716206B (zh) * 2023-04-10 2023-11-14 微康益生菌(苏州)股份有限公司 一种参与肠道皮肤轴调控并改善皮肤健康状态的长双歧杆菌婴儿亚种及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2353495A (en) 1940-12-31 1944-07-11 Standard Oil Co Catalytic conversion system
JP5762951B2 (ja) * 2008-05-15 2015-08-12 ダブリュ．・ヘルス・エル．ピー．Ｗ． Ｈｅａｌｔｈ Ｌ．Ｐ． 分泌性免疫グロブリンの豊富な乳画分の製造方法
EP2138187A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and infection
EP2138186A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and inflammation
EP2762490A1 (de) * 2013-01-31 2014-08-06 DMK Deutsches Milchkontor GmbH Verfahren zur Gewinnung von Immunoglobulinen aus Kolostralmilch

Also Published As

Publication number Publication date
US20220296706A1 (en) 2022-09-22
EP3990485A1 (en) 2022-05-04
BR112021024793A2 (pt) 2022-04-19
WO2020260502A1 (en) 2020-12-30
CL2021003328A1 (es) 2022-09-30
AU2020306842A1 (en) 2021-12-16
CN114502582A (zh) 2022-05-13

Similar Documents

Publication Publication Date Title
MX2021015591A (es) Composiciones que comprenden iga secretora y probioticos.
WO2019014395A8 (en) GENERATION OF WATER-SOLUBLE CANNABINOID COMPOUNDS IN PLANT CELL SUSPENSION YEAST AND CROPS AND MATERIAL COMPOSITIONS
WO2018109170A3 (en) Il-11ra antibodies
WO2018109174A3 (en) Il-11 antibodies
MX2021013581A (es) Composiciones de nanoemulsiones que comprenden ingredientes biologicamente activos.
MX2022001061A (es) Agentes de interleuquina-2 y usos de los mismos.
MX2021010827A (es) Materiales funcionales de origen vegetal.
JOP20210305A1 (ar) صيغ إيماتينيب وتصنيعها واستخداماتها
MX2021006674A (es) Composiciones para estabilizar bacterias y usos de las mismas.
EP3844169A4 (en) COMPOSITIONS, FORMULATIONS AND PRODUCTION AND PURIFICATION OF INTERLEUKINS
MX2020001885A (es) Formulaciones de daptomicina.
ZA201900070B (en) Antibodies with low immunogenicity and uses thereof
CR20210471A (es) Anticuerpos claudina 6 y usos de los mismos
WO2020086965A8 (en) Polymer-lipids and compositions
GB2568181A (en) Wheat
MX2020011986A (es) Composiciones que comprenden glucosa y hemicelulosa y su uso.
MX2022001449A (es) Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos.
EP3880828A4 (en) PLANT VECTORS, COMPOSITIONS AND ASSOCIATED USES
WO2020146700A8 (en) Lipid nanoparticles
MX2021005157A (es) Composiciones, metodos para hacer y utilizar extracto de salvado de arroz.
WO2018135843A3 (ko) 탈모 예방, 발모 촉진 또는 성기능 개선능이 있는 락토바실러스 퍼멘텀 균주 및 이를 포함하는 조성물
MX2018016037A (es) Variantes de lipasa y composiciones que comprenden tensioactivo y variante de lipasa.
MX2022001534A (es) Composiciones de probioticos a base de plantas fermentadas y procesos de preparacion de las mismas.
EP4058568A4 (en) PLANT VECTORS, COMPOSITIONS AND RELATED USES
MX2022001641A (es) Composiciones fermentadas y procedimientos de preparacion de las mismas.